1. Management of Atrial Fibrillation by Canadian Electrophysiologists After Early Termination of the PALLAS Study 
Kiarash Mohajer, BSc, Ben Fregeau, BSc, Vinay Garg, BSc, Allan Skanes, MD, FRCPC, Christopher S. Simpson, MD, FACC, FRCPC, Damian P. Redfearn, MB, ChB, MRCPI, Kevin A. Michael, MB, ChB, MRCPI, Adrian Baranchuk, MD, FACC, FRCPC 
Canadian Journal of Cardiology 
Volume 29, Issue 1, Pages 131.e1-131.e2 (January 2013)
DOI: /j.cjca
Copyright © 2013 Canadian Cardiovascular Society Terms and Conditions

2. Figure 1
Proportions of antiarrhythmic medications prescribed by Canadian electrophysiologists for the management of atrial fibrillation after the ATHENA [A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter] trial.
Canadian Journal of Cardiology  , 131.e1-131.e2DOI: ( /j.cjca )
Copyright © 2013 Canadian Cardiovascular Society Terms and Conditions